Please Wait...

BAP // Bone Alkaline Phosphatase

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Alkaline phosphatase (ALP) catalyzes the hydrolysis of phosphomonoesters with alcohol and inorganic phosphate release. In human body, there are four ALP isoenzymes coded by four gene loci: tissue nonspecific ALP or liver/bone/kidney ALP, placental ALP, germ cell ALP and intestinal ALP. Liver, bone and kidney ALP are coded by the same gene but differs in posttranslational modification (Weiss et al., 1986). Bone ALP (BAP) is localized on the surface of osteoblasts and associated with bone formation. BAP can be released and measured in serum (Garnero and Delmas, 1993). A rise in BAP levels in serum is indicative of an increasing bone turnover.

Bioclinica Lab employs an automated chemiluminescent immunoassay for the measurement of BAP in serum.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

With many clinical trials slowed or terminated, investments in new technologies are difficult. Yet, a #CTMS with a… https://t.co/VRIhWWf4tE
Bioclinica (5 days ago)
With Bioclinica #CTMS, sponsors & CROs have access to a full-featured, scalable system - a single, centralized sour… https://t.co/7ACrv8cvuF
Bioclinica (1 week ago)
Now available: a DIY #EDC solution. From study start-up to close-out, Bioclinica EDC Solo is an efficient, cost-eff… https://t.co/vFhC7ITfZV
Bioclinica (2 weeks ago)
Reduce the number of user requirement iterations and UAT findings during the #IRT build process. With the agile app… https://t.co/TJt2sZlrFP
Bioclinica (2 weeks ago)
Don't compromise with manual systems and spreadsheets. As an entry-level system with phased implementation, Bioclin… https://t.co/qIpi1MESXw
Bioclinica (3 weeks ago)
According to our recent poll, 45% of respondents had neither a #CTMS nor an #eTMF system, while only 24% had both.… https://t.co/l4dKC7pBQo
Bioclinica (3 weeks ago)